WallStreetZen

NYSE: JNJ
Johnson & Johnson Stock Forecast, Predictions & Price Target

Analyst price target for JNJ

Based on 6 analysts offering 12 month price targets for Johnson & Johnson.
Min Forecast
$180.00+8.81%
Avg Forecast
$188.33+13.85%
Max Forecast
$200.00+20.9%

Should I buy or sell JNJ stock?

Based on 6 analysts offering ratings for Johnson & Johnson.
Buy
Strong Buy
2 analysts 33.33%
Buy
3 analysts 50%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

JNJ stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Morgan Stanley
Top 12%
89
HoldDowngrades$187.00+13.05%2021-09-07
Raymond James
Top 8%
93
BuyMaintains$183.00+10.63%2021-01-27
Credit Suisse
Top 15%
86
BuyMaintains$193.00+16.67%2021-01-27
Anonymous
Morgan Stanley
Strong BuyMaintains$187.00+13.05%2021-01-27
SVB Leerink
Top 18%
83
BuyMaintains$200.00+20.90%2021-01-27
Cantor Fitzgerald
Bottom 3%
3
Strong BuyMaintains$180.00+8.81%2020-10-14

1 of 1

Forecast return on equity

Is JNJ forecast to generate an efficient return?
Company
44.38%
Industry
74.59%
Market
30.41%
JNJ's Return on Equity is forecast to be high in 3 years (44.38%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is JNJ forecast to generate an efficient return on assets?
Company
17.5%
Industry
16.42%
Market
15.13%
JNJ is forecast to generate higher Return on Assets (17.5%) than the US Drug Manufacturers - General industry average (16.42%)
Forecast

JNJ earnings per share forecast

What is JNJ's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$9.65+43.21%
Avg 2 year Forecast
$10.30+52.87%
Avg 3 year Forecast
$11.14+65.28%
JNJ's earnings are forecast to grow at a rate of 17.99% per year, which is not exceptional
Forecast

JNJ revenue forecast

What is JNJ's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$94.3B+5.77%
Avg 2 year Forecast
$97.7B+9.56%
Avg 3 year Forecast
$102.7B+15.11%
JNJ's revenue is forecast to grow at a rate of 4.67% per year, which is not exceptional
Forecast

JNJ earnings growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
17.99%
Industry
21.93%
Market
18.84%
JNJ's earnings are forecast to grow slower (17.99% per year) than the US Drug Manufacturers - General industry average (21.93%)
Forecast
JNJ's earnings are forecast to grow slower (17.99% per year) than the US market average (18.84%)
Forecast
JNJ's earnings are forecast to grow faster (17.99% per year) than the risk-free savings rate (1.3%)
Forecast

JNJ revenue growth forecast

How is JNJ forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
4.67%
Industry
4.44%
Market
12.2%
JNJ's revenues are forecast to grow faster (4.67% per year) than the US Drug Manufacturers - General industry average (4.44%)
Forecast
JNJ's revenues are forecast to grow slower (4.67% per year) than the US market average (12.2%)
Forecast

Johnson & Johnson Stock Forecast FAQ

Is Johnson & Johnson Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: JNJ) stock is to Buy JNJ stock.

Out of 6 analysts, 2 (33.33%) are recommending JNJ as a Strong Buy, 3 (50%) are recommending JNJ as a Buy, 1 (16.67%) are recommending JNJ as a Hold, 0 (0%) are recommending JNJ as a Sell, and 0 (0%) are recommending JNJ as a Strong Sell.

What is JNJ's earnings growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual earnings growth rate of 17.99% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 21.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.84%.

Johnson & Johnson's earnings in 2021 is $17,767,000,000.On average, 9 Wall Street analysts forecast JNJ's earnings for 2021 to be $25,409,243,648, with the lowest JNJ earnings forecast at $25,271,828,083, and the highest JNJ earnings forecast at $25,482,426,651. On average, 9 Wall Street analysts forecast JNJ's earnings for 2022 to be $27,123,252,739, with the lowest JNJ earnings forecast at $25,219,178,441, and the highest JNJ earnings forecast at $27,772,686,071.

In 2023, JNJ is forecast to generate $29,325,850,505 in earnings, with the lowest earnings forecast at $28,773,029,266 and the highest earnings forecast at $29,747,047,640.

What is JNJ's revenue growth forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's forecast annual revenue growth rate of 4.67% is forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 4.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.2%.

Johnson & Johnson's revenue in 2021 is $89,190,000,000.On average, 5 Wall Street analysts forecast JNJ's revenue for 2021 to be $248,336,214,286,908, with the lowest JNJ revenue forecast at $247,966,650,655,940, and the highest JNJ revenue forecast at $248,823,155,029,393. On average, 5 Wall Street analysts forecast JNJ's revenue for 2022 to be $257,240,032,141,858, with the lowest JNJ revenue forecast at $253,671,239,349,304, and the highest JNJ revenue forecast at $261,356,665,517,614.

In 2023, JNJ is forecast to generate $270,268,949,434,973 in revenue, with the lowest revenue forecast at $268,852,500,325,659 and the highest revenue forecast at $272,854,136,353,708.

What is JNJ's forecast return on assets (ROA) for 2021-2024?

(NYSE: JNJ) forecast ROA is 17.5%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.42%.

What is JNJ's Price Target?

According to 6 Wall Street analysts that have issued a 1 year JNJ price target, the average JNJ price target is $188.33, with the highest JNJ stock price forecast at $200.00 and the lowest JNJ stock price forecast at $180.00.

On average, Wall Street analysts predict that Johnson & Johnson's share price could stay at $188.33 by Sep 7, 2022. The average Johnson & Johnson stock price prediction forecasts a potential downside of N/A from the current JNJ share price of $165.42.

What is JNJ's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: JNJ) Johnson & Johnson's current Earnings Per Share (EPS) is $6.74. On average, analysts forecast that JNJ's EPS will be $9.65 for 2021, with the lowest EPS forecast at $9.60, and the highest EPS forecast at $9.68. On average, analysts forecast that JNJ's EPS will be $10.30 for 2022, with the lowest EPS forecast at $9.58, and the highest EPS forecast at $10.55. In 2023, JNJ's EPS is forecast to hit $11.14 (min: $10.93, max: $11.30).

What is JNJ's forecast return on equity (ROE) for 2021-2024?

(NYSE: JNJ) forecast ROE is 44.38%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.